Who is sponsoring NCT04848441?

NCT04848441 is sponsored by Umeå University.

What drugs are being tested in NCT04848441?

Interventions in NCT04848441: The COVID-19 vaccines BNT162b2, mRNA-1273 and ChAdOx1.

What condition does NCT04848441 study?

NCT04848441 studies Vaccination; Infection, Covid19.

Is NCT04848441 still recruiting?

NCT04848441 is currently status unknown. Last updated 19 April 2021.

Last reviewed 2021-04-19 · How we verify

NCT04848441

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk of COVID-19 Infection After Vaccination

Status unknown Last updated 19 April 2021

What this trial tests

trial testing The COVID-19 vaccines BNT162b2, mRNA-1273 and ChAdOx1 in Vaccination; Infection in 2,000,000 participants. Status unknown.

Timeline

1 May 2021

Primary endpoint
1 August 2021

1 August 2021

Quick facts

Lead sponsor	Umeå University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	2,000,000
Start date	1 May 2021
Primary completion	1 August 2021
Estimated completion	1 August 2021

Drugs / interventions tested

The COVID-19 vaccines BNT162b2, mRNA-1273 and ChAdOx1

Conditions studied

Vaccination; Infection — all drugs for Vaccination; Infection →
Covid19 — all drugs for Covid19 →

Sponsor

Umeå University

Who can join

Adults 0 to 110, any sex, with Vaccination; Infection or Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this observational nationwide study is to evaluate the effects of three different COVID-19 vaccines for the outcome of different severities of incident COVID infection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vaccination; Infection

Currently open trials in the same condition.

NCT06492187 — Triage Survey for Infectious Disease Eligibility · recruiting
NCT05898464 — Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV · Phase 4 · active not recruiting
NCT04970836 — The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort · NA · recruiting

Other Umeå University trials

Trials by the same sponsor.

NCT07407946 — Blended Trauma-Focused Cognitive Behavioral Therapy With Compassion · NA · recruiting
NCT07346820 — VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation · not yet recruiting
NCT07417358 — Single-Stapled Technique for Colorectal Anastomosis · recruiting
NCT07316426 — Preoptimisation in Ventral Hernia Surgery · NA · recruiting
NCT07170722 — Sub-threshold DRG Stimulation vs Sham in Established Responders · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04848441 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Umeå University
Last refreshed: 19 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04848441.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing